Radius Health, Inc. (RDUS)
USD 29.11
(0.73%)
USD 29.11
(0.73%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 365.31 Million USD | -1.76% |
| 2022 | 371.87 Million USD | 77.48% |
| 2021 | 209.53 Million USD | -8.67% |
| 2020 | 229.42 Million USD | -19.95% |
| 2019 | 286.6 Million USD | -19.71% |
| 2018 | 356.94 Million USD | 18.7% |
| 2017 | 300.72 Million USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 101.15 Million USD | 677.79% |
| 2013 | 13 Million USD | -37.49% |
| 2012 | 20.8 Million USD | 76.82% |
| 2011 | 11.76 Million USD | 15206.36% |
| 2010 | 76.87 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 469.34 Million USD | 10.76% |
| 2023 Q1 | 423.75 Million USD | -11.1% |
| 2023 Q4 | 399.11 Million USD | 9.25% |
| 2023 Q3 | 365.31 Million USD | -22.16% |
| 2023 FY | 365.31 Million USD | -1.76% |
| 2022 Q1 | 340.14 Million USD | 0.14% |
| 2022 Q3 | 371.87 Million USD | 9.25% |
| 2022 Q4 | 476.65 Million USD | 28.18% |
| 2022 FY | 371.87 Million USD | 77.48% |
| 2022 Q2 | 340.4 Million USD | 0.08% |
| 2021 Q2 | 339.29 Million USD | -1.05% |
| 2021 Q4 | 339.67 Million USD | 0.07% |
| 2021 Q3 | 339.41 Million USD | 0.04% |
| 2021 Q1 | 342.88 Million USD | 13670.48% |
| 2021 FY | 209.53 Million USD | -8.67% |
| 2020 FY | 229.42 Million USD | -19.95% |
| 2020 Q2 | 283.75 Million USD | -7.6% |
| 2020 Q3 | 225.1 Million USD | -20.67% |
| 2020 Q4 | 2.49 Million USD | -98.89% |
| 2020 Q1 | 307.07 Million USD | 7.14% |
| 2019 Q3 | 270.69 Million USD | -12.4% |
| 2019 Q2 | 309.01 Million USD | -2.28% |
| 2019 Q4 | 286.6 Million USD | 5.88% |
| 2019 Q1 | 316.23 Million USD | -11.41% |
| 2019 FY | 286.6 Million USD | -19.71% |
| 2018 Q3 | 348.3 Million USD | -1.16% |
| 2018 FY | 356.94 Million USD | 18.7% |
| 2018 Q1 | 348.73 Million USD | 15.97% |
| 2018 Q2 | 352.4 Million USD | 1.05% |
| 2018 Q4 | 356.94 Million USD | 2.48% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | 300.72 Million USD | 0.0% |
| 2017 Q4 | 300.72 Million USD | 63.52% |
| 2017 Q3 | 183.9 Million USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2015 FY | - USD | -100.0% |
| 2015 Q1 | 24.46 Million USD | -75.82% |
| 2015 Q2 | 24.53 Million USD | 0.28% |
| 2014 Q3 | 24.32 Million USD | -52.26% |
| 2014 Q2 | 50.94 Million USD | 401.42% |
| 2014 Q1 | 10.16 Million USD | -21.87% |
| 2014 FY | 101.15 Million USD | 677.79% |
| 2014 Q4 | 101.15 Million USD | 315.89% |
| 2013 Q1 | 18.94 Million USD | -8.92% |
| 2013 Q3 | 15.2 Million USD | -10.99% |
| 2013 Q4 | 13 Million USD | -14.47% |
| 2013 FY | 13 Million USD | -37.49% |
| 2013 Q2 | 17.08 Million USD | -9.85% |
| 2012 Q2 | 22.91 Million USD | 101.34% |
| 2012 Q3 | 22.02 Million USD | -3.91% |
| 2012 Q4 | 20.8 Million USD | -5.53% |
| 2012 FY | 20.8 Million USD | 76.82% |
| 2012 Q1 | 11.38 Million USD | -3.26% |
| 2011 Q4 | 11.76 Million USD | 103.11% |
| 2011 Q3 | 5.79 Million USD | 1.13% |
| 2011 Q2 | 5.72 Million USD | 6437.32% |
| 2011 Q1 | 87.62 Thousand USD | 13.98% |
| 2011 FY | 11.76 Million USD | 15206.36% |
| 2010 Q2 | - USD | -100.0% |
| 2010 FY | 76.87 Thousand USD | 0.0% |
| 2010 Q4 | 76.87 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | 6.5 Million USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | -100.0% |
| 2009 Q1 | 6.25 Million USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2008 Q2 | 4.47 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | 3.12 Million USD | -30.2% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -2056.766% |
| PainReform Ltd. | 86 Thousand USD | -424682.558% |
| Alvotech | 1.07 Billion USD | 66.032% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 45.822% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | -15.852% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | -269.668% |
| Journey Medical Corporation | 17.73 Million USD | -1960.423% |
| Dynavax Technologies Corporation | 256.91 Million USD | -42.193% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 32.468% |
| Bright Green Corporation | 1.85 Million USD | -19627.635% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 37.665% |
| Embecta Corp. | 1.63 Billion USD | 77.704% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -55443.595% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -55443.595% |
| SCYNEXIS, Inc. | 15.08 Million USD | -2322.5% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -4313.81% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -13698.648% |
| Alpha Teknova, Inc. | 30.45 Million USD | -1099.399% |
| Safety Shot Inc | 1.54 Million USD | -23484.192% |
| Procaps Group, S.A. | 285.93 Million USD | -27.761% |
| Cosmos Health Inc. | 12.42 Million USD | -2840.393% |
| Theratechnologies Inc. | 58.96 Million USD | -519.511% |
| Harrow Health, Inc. | 190.5 Million USD | -91.763% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -59984.375% |
| Biofrontera Inc. | 5.39 Million USD | -6666.309% |
| DURECT Corporation | 20.74 Million USD | -1660.884% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -779.7% |
| Cronos Group Inc. | 2.53 Million USD | -14282.753% |
| OptiNose, Inc. | 131.74 Million USD | -177.28% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 48.946% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | -905.735% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -31043.319% |
| Organogenesis Holdings Inc. | 119.35 Million USD | -206.083% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -1882.328% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -6563.309% |
| ProPhase Labs, Inc. | 21.38 Million USD | -1608.667% |
| Phibro Animal Health Corporation | 525.45 Million USD | 30.477% |
| Procaps Group S.A. | 285.93 Million USD | -27.761% |
| TherapeuticsMD, Inc. | 8 Million USD | -4463.56% |
| Viatris Inc. | 18.12 Billion USD | 97.984% |
| Rockwell Medical, Inc. | 13.43 Million USD | -2618.305% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -2314.654% |
| SIGA Technologies, Inc. | 1.46 Million USD | -24852.92% |
| Tilray Brands, Inc. | 387.31 Million USD | 5.681% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | -180.234% |
| Shineco, Inc. | 29.65 Million USD | -1131.817% |
| PetIQ, Inc. | 468.3 Million USD | 21.992% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -610719.804% |
| Incannex Healthcare Limited | 373 Thousand USD | -97839.142% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 14.726% |
| Alimera Sciences, Inc. | 67.39 Million USD | -442.015% |
| Assertio Holdings, Inc. | 40.91 Million USD | -792.924% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -33486.009% |
| Clever Leaves Holdings Inc. | 2.08 Million USD | -17404.217% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -35260.342% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | -932.424% |
| Hempacco Co., Inc. | 13.72 Million USD | -2561.757% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.07 Billion USD | 66.032% |
| Eagle Pharmaceuticals, Inc. | 62.46 Million USD | -484.819% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 40.787% |
| Currenc Group, Inc. | 31.94 Million USD | -1043.617% |
| Kamada Ltd. | 8.74 Million USD | -4075.489% |
| Indivior PLC | 281.6 Million USD | -29.727% |
| Evoke Pharma, Inc. | 5 Million USD | -7206.26% |
| Flora Growth Corp. | 3.67 Million USD | -9848.611% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -35260.342% |
| Evolus, Inc. | 126.54 Million USD | -188.68% |
| HUTCHMED (China) Limited | 86.13 Million USD | -324.136% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 41.423% |
| Akanda Corp. | 3.99 Million USD | -9035.586% |